Vaccines

Mighty mRNA molecules have won the COVID-19 vaccine race, but there is room for improvement.

How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”

Billions of vaccine doses equate to a need for billions of primary packaging units – and glass vials are still top dog.

We get the rundown on mRNA vaccine manufacturing. How were the vaccines developed so quickly?

Let’s not ride roughshod over patient autonomy when it comes to national vaccination campaigns.

Kevin Ott from the BPSA says we should not forget how single-use plastics are saving lives.

How has COVID-19 consumer stockpiling affected the supply chains for pharma ingredients?

Experts explain the challenges of transporting vaccines across the globe.

How did AstraZeneca end up in a PR nightmare?

Whitney Winters discusses the impact the pandemic has had on the supply chain for primary packaging.